Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update

K Engle, G Kumar - European journal of medicinal chemistry, 2022 - Elsevier
Chemotherapy is one of the most common treatments for cancer that uses one or more anti-
cancer drugs as a part of the standardized chemotherapy regimen. Cytotoxic chemicals …

Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters

A Sajid, H Rahman, SV Ambudkar - Nature Reviews Cancer, 2023 - nature.com
Cancer cells frequently display intrinsic or acquired resistance to chemically diverse
anticancer drugs, limiting therapeutic success. Among the main mechanisms of this …

Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)

H Zhang, H Xu, CR Ashby Jr, YG Assaraf… - Medicinal research …, 2021 - Wiley Online Library
Multidrug resistance (MDR) remains one of the major impediments for efficacious cancer
chemotherapy. Increased efflux of multiple chemotherapeutic drugs by transmembrane ATP …

ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates

JQ Wang, ZX Wu, Y Yang, QX Teng… - Journal of Evidence …, 2021 - Wiley Online Library
The ATP‐binding cassette (ABC) transporter superfamily is one of the largest membrane
protein families existing in wide spectrum of organisms from prokaryotes to human. ABC …

[HTML][HTML] Multidrug resistance of cancer cells and the vital role of P-glycoprotein

C Karthika, R Sureshkumar, M Zehravi, R Akter, F Ali… - Life, 2022 - mdpi.com
P-glycoprotein (P-gp) is a major factor in the multidrug resistance phenotype in cancer cells.
P-gp is a protein that regulates the ATP-dependent efflux of a wide range of anticancer …

Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1-and ABCG2-overexpressing cancer cells

N Ji, Y Yang, CY Cai, ZN Lei, JQ Wang, P Gupta… - Cancer letters, 2019 - Elsevier
Overexpression of ATP-binding cassette (ABC) transporters is one of the most important
mechanisms responsible for the development of multidrug resistance (MDR). Selonsertib, a …

Cell signaling and cancer: a mechanistic insight into drug resistance

M Panda, BK Biswal - Molecular biology reports, 2019 - Springer
Drug resistance is a major setback for advanced therapeutics in multiple cancers. The
increasing prevalence of this resistance is a growing concern and bitter headache for the …

Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2

CP Wu, SH Hsiao, YS Wu - Drug Resistance Updates, 2023 - Elsevier
The overexpression of the human ATP-binding cassette (ABC) transporters in cancer cells is
a common mechanism involved in developing multidrug resistance (MDR). Unfortunately …

[HTML][HTML] Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo

Y Zhang, C Li, C Xia, KK Wah To, Z Guo, C Ren… - Cell Communication and …, 2022 - Springer
Background Multidrug resistance (MDR) is a complex phenomenon that frequently leads to
chemotherapy failure during cancer treatment. The overexpression of ATP-binding cassette …

[HTML][HTML] The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells

HL Gao, Q Cui, JQ Wang, CR Ashby Jr… - Frontiers in …, 2023 - frontiersin.org
Introduction: The overexpression of ATP-binding cassette (ABC) transporters, ABCB1 and
ABCG2, are two of the major mediators of multidrug resistance (MDR) in cancers. Although …